Literature DB >> 20382444

Increasing incidence of candidaemia: long-term epidemiological trends, Queensland, Australia, 1999-2008.

E G Playford1, G R Nimmo, M Tilse, T C Sorrell.   

Abstract

Given variability in the epidemiology of candidaemia and a relative paucity of contemporary longitudinal data, a passive laboratory-based surveillance study was performed to assess the epidemiology of candidaemia in all public healthcare facilities in Queensland, Australia over the period 1999-2008. Demographic and microbiological data on all candidaemia episodes, together with appropriate denominators (admissions and patient-days), were collected from laboratory and administrative information systems. From 1999 to 2008, 1137 episodes occurred (overall incidence-density: 0.45 per 10 000 patient-days) with a 3.5-fold increase in density (P<0.0001 for trend). Candidaemia episodes originating in traditional high-risk areas either decreased (haemato-oncology and paediatric wards) or remained stable (intensive care units). Episodes on adult medical/surgical wards increased significantly over time, accounting for 60% of the total by 2008. The relative proportion caused by Candida albicans decreased and Candida parapsilosis increased (both P<0.01). The proportion of fluconazole-resistant isolates did not change. The increasing occurrence of candidaemia outside traditional high-risk areas and the emergence of C. parapsilosis present new challenges for preventive and early intervention strategies. Copyright 2010 The Hospital Infection Society. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20382444     DOI: 10.1016/j.jhin.2010.01.022

Source DB:  PubMed          Journal:  J Hosp Infect        ISSN: 0195-6701            Impact factor:   3.926


  14 in total

1.  Waikialoid A suppresses hyphal morphogenesis and inhibits biofilm development in pathogenic Candida albicans.

Authors:  Xiaoru Wang; Jianlan You; Jarrod B King; Douglas R Powell; Robert H Cichewicz
Journal:  J Nat Prod       Date:  2012-03-08       Impact factor: 4.050

2.  Validation of a modified algorithm for the identification of yeast isolates using matrix-assisted laser desorption/ionisation time-of-flight mass spectrometry (MALDI-TOF MS).

Authors:  B H Van Herendael; P Bruynseels; M Bensaid; T Boekhout; T De Baere; I Surmont; A H Mertens
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-08-23       Impact factor: 3.267

3.  Outcomes associated with routine systemic antifungal therapy in critically ill patients with Candida colonization.

Authors:  David Ferreira; Frederic Grenouillet; Gilles Blasco; Emmanuel Samain; Thierry Hénon; Alain Dussaucy; Laurence Millon; Mariette Mercier; Sebastien Pili-Floury
Journal:  Intensive Care Med       Date:  2015-04-18       Impact factor: 17.440

4.  Management of invasive candidiasis in the intensive care unit.

Authors:  E Geoffrey Playford; Jeff Lipman; Tania C Sorrell
Journal:  Drugs       Date:  2010-05-07       Impact factor: 9.546

5.  Prospective observational multicenter study to define a diagnostic algorithm for biliary candidiasis.

Authors:  Philipp Lenz; Franziska Eckelskemper; Thomas Erichsen; Tim Lankisch; Alexander Dechêne; Gabriele Lubritz; Frank Lenze; Torsten Beyna; Hansjörg Ullerich; Andre Schmedt; Dirk Domagk
Journal:  World J Gastroenterol       Date:  2014-09-14       Impact factor: 5.742

6.  Diagnostic issues, clinical characteristics, and outcomes for patients with fungemia.

Authors:  Maiken Cavling Arendrup; Sofia Sulim; Anette Holm; Lene Nielsen; Susanne Dam Nielsen; Jenny Dahl Knudsen; Niels Erik Drenck; Jens Jørgen Christensen; Helle Krogh Johansen
Journal:  J Clin Microbiol       Date:  2011-06-29       Impact factor: 5.948

7.  Candida bloodstream infections: comparison of species distributions and antifungal resistance patterns in community-onset and nosocomial isolates in the SENTRY Antimicrobial Surveillance Program, 2008-2009.

Authors:  Michael A Pfaller; Gary J Moet; Shawn A Messer; Ronald N Jones; Mariana Castanheira
Journal:  Antimicrob Agents Chemother       Date:  2010-11-29       Impact factor: 5.191

8.  Small-molecule suppressors of Candida albicans biofilm formation synergistically enhance the antifungal activity of amphotericin B against clinical Candida isolates.

Authors:  Jianlan You; Lin Du; Jarrod B King; Brian E Hall; Robert H Cichewicz
Journal:  ACS Chem Biol       Date:  2013-02-14       Impact factor: 5.100

9.  Candidaemia observed at a university hospital in Milan (northern Italy) and review of published studies from 2010 to 2014.

Authors:  Laura Milazzo; Anna Maria Peri; Cristina Mazzali; Romualdo Grande; Chiara Cazzani; Davide Ricaboni; Antonio Castelli; Ferdinando Raimondi; Carlo Magni; Massimo Galli; Spinello Antinori
Journal:  Mycopathologia       Date:  2014-07-24       Impact factor: 2.574

10.  Species distribution and in vitro antifungal susceptibility profiles of yeast isolates from invasive infections during a Portuguese multicenter survey.

Authors:  I Faria-Ramos; J Neves-Maia; E Ricardo; J Santos-Antunes; A T Silva; S Costa-de-Oliveira; E Cantón; A G Rodrigues; C Pina-Vaz
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-07-11       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.